Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Witty's Successor: The Shortlist

This article was originally published in Scrip

Executive Summary

"The board will now start a formal search for a successor and will consider internal and external candidates for the role," said GlaxoSmithKline PLC's chair Sir Philip Hampton, and the games begin.

Advertisement

Related Content

GSK Management Shake Up Ahead Of New CEO Sees Hussain Out, AZ's Miels In
Will GSK’s Walmsley Be Feared As ‘Witty But Worse’?
GSK’s New CEO Designate Walmsley Fortifies Volume Growth Strategy
What’s On CEO Andrew Witty’s To-Do List Before Exiting GSK
Advertisement
UsernamePublicRestriction

Register

SC064770

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel